AIP
ALAB icon

Arrowpoint Investment Partners’s Astera Labs ALAB Stock Holding History

Arrowpoint Investment Partners’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,900
Closed -$412K – 908
2025
Q1 		$412K Buy
+6,900
New +$638K 0.05% 433

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

Arrowpoint Investment Partners's ALAB Position: Q4 2025 in Review

Arrowpoint Investment Partners sold out of Astera Labs (ALAB) in Q4 2025, closing a stake of 17,382 shares — an estimated $3.4M sold.

Arrowpoint Investment Partners first reported a position in ALAB in Q4 2024 and held it in 3 quarters. The position peaked at $3.4M in Q3 2025. 702 funds tracked by Wall St. Rank hold ALAB as of Q4 2025.

  • Arrowpoint Investment Partners reported no remaining Astera Labs position as of Q4 2025 after selling out during the quarter.
  • Arrowpoint Investment Partners sold 17,382 Astera Labs shares in Q4 2025, an estimated $3.4M.
  • Arrowpoint Investment Partners first reported a position in Astera Labs in Q4 2024 and held it in 3 quarters.
  • Arrowpoint Investment Partners's Astera Labs position peaked at $3.4M in Q3 2025.
  • 702 funds tracked by Wall St. Rank held Astera Labs as of Q4 2025.

Based on Arrowpoint Investment Partners's 13F filing for Q4 2025, filed 11 Feb 2026.